Immunohistochemical expression of Ki-67 and p53 in colorectal carcinoma

AUTHOR(s) : Das Mili1, Baruah Sampriti2, Chaubey RN3, Chaubey Jyoti4, Saharia Jahanabi5
DOI No. : 10.31741/ijhrmlp.v5.i1.2018.18


Objectives: To investigate the expression of Ki-67 and p53 in colorectal carcinomas and to correlate expression patterns of these markers with histopathological grades of colorectal carcinoma. Materials and methods: We determined immunohistochemically the expression of Ki-67 and p53 antibodies in 62 cases of colorectal adenocarcinomas. Results: Mean Ki-67 index in our study was 33.9%. Mean Ki-67 increased with dedifferentiation of tumor (Grade I-18.8%, Grade II-33.2%, Grade III-49.1%). The difference in mean Ki-67 index is statistically significant with histopathological grade. (p <0.001). p53 overexpression was seen in 69.3% cases. Percentage of diffuse p53 positivity increased with dedifferentiation of tumor. p53 positivity rate was observed in 22.2% cases of well differentiated carcinoma and increased from 76.2% to 81.8% in moderately to poorly differentiated carcinoma. However, the difference was statistically insignificant with histopathological grade. Conclusion: As the result of this study it is concluded that in colorectal carcinoma Ki-67 LI correlated with grade and increases with the dedifferentiation of tumor and also p53 over expression increases with dedifferentiation of tumour. Thus, the evaluations of expression of p53 and Ki-67 can be used as a poor prognostic marker allowing the identification of aggressive forms.

Registered Office Address:
House No: One, Karmabir Bordoloi Path, Wireless,
Rukmini Nagar, Dispur-06, Assam, India

Mobile: 09435017802
IJHRMLP is an open-access journal, and the articles published are instantly available to read and use again. The published articles thus can be downloaded, shared, and reused without restriction if the contributing original authors are appropriately cited. Author(s) retain the copyright of their article, with articles licensed to AHRME and the journal following the Creative Commons Attribution License (CC-BY).
Maintain By Prism Infosys